TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Lymphadenopathy
Study results from C.N. Ferreira and colleagues broaden understanding of lymphadenopathy
September 2nd, 2008
According to recent research published in the journal Nature Clinical Practice Gastroenterology & Hepatology, " A 62-year-old white woman was admitted to hospital with a 2-month history of progressive, painless, left supraclavicular and axillary lymph node enlargement. The patient's history was significant for chronic HCV infection, for which she had just completed a 48-week course of treatment with pegylated interferon a (180 mu g once weekly) plus ribavirin (1,000 mg daily)." "She attained an end-of-treatment response and subsequent qualitative measurement of HCV RNA confirmed a sustained virological response. The onset of progressive painless lymph node...
Source: TB & Outbreaks Week (2008-09-02)
|
